Begin typing your search above and press return to search.
Covid antibody cocktail administered to Donald Trump launched in India, to cost a bomb!
By: Tupaki Desk | 25 May 2021 12:04 PM GMT
In the light of India facing a severe shortage of vaccine doses, one more vaccine to cure the ongoing novel Coronavirus was launched in India. The vaccines will help in treating Covid-19 patients with mild to moderate symptoms.
Drug manufacturer Roche India announced that the first batch of antibody cocktail against Covid-19 was launched in India. The antibody cocktail was priced at Rs 59,750 per dose, making it the costliest vaccine in the country.
The antibody cocktail was earlier used to treat Donald Trump, the then President of the United States when he had contacted the virus during the first wave of the virus.
The drug company in a statement said that the first batch of vaccine doses was launched in India. Every dose of the vaccine comes with 600 mg of Casirivimab and Imdevimab. Each dose was priced at ₹ 59,750, while the multi-dose pack was priced at Rs 1,19,500, which could treat two Covid patients.
Leading Pharma giant Cipla headquartered in the financial capital of India, Mumbai will market the drug in the country. The second batch of the costly drug will be ready in India by the mid of June.
"The first batch of the antibody cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June. In total they can potentially benefit two lakh patients as each of the one lakh packs that will be available in India offers treatment for two patients," the official statement read.
Given the fact that it is the costliest drug, it will not be available at all the vaccine centres. The Covid antibody cocktail will be made available at the leading hospitals and facilities only.
Notably, the costly drug has got the required Emergency Use Authorisation (EUA) for the antibody cocktail in the country by the Central Drugs Standards Control Organisation (CDSCO) recently.
Drug manufacturer Roche India announced that the first batch of antibody cocktail against Covid-19 was launched in India. The antibody cocktail was priced at Rs 59,750 per dose, making it the costliest vaccine in the country.
The antibody cocktail was earlier used to treat Donald Trump, the then President of the United States when he had contacted the virus during the first wave of the virus.
The drug company in a statement said that the first batch of vaccine doses was launched in India. Every dose of the vaccine comes with 600 mg of Casirivimab and Imdevimab. Each dose was priced at ₹ 59,750, while the multi-dose pack was priced at Rs 1,19,500, which could treat two Covid patients.
Leading Pharma giant Cipla headquartered in the financial capital of India, Mumbai will market the drug in the country. The second batch of the costly drug will be ready in India by the mid of June.
"The first batch of the antibody cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June. In total they can potentially benefit two lakh patients as each of the one lakh packs that will be available in India offers treatment for two patients," the official statement read.
Given the fact that it is the costliest drug, it will not be available at all the vaccine centres. The Covid antibody cocktail will be made available at the leading hospitals and facilities only.
Notably, the costly drug has got the required Emergency Use Authorisation (EUA) for the antibody cocktail in the country by the Central Drugs Standards Control Organisation (CDSCO) recently.
